Australia
Austria
Belgium
China
Czech Republic
Denmark
Estonia
Finland
France
Germany
Hungary
India
Ireland
Italy
Japan
Kazakhstan
Latvia
Lithuania
Malaysia
Netherlands
Norway
Poland
Singapore
Slovenia
Spain
Sweden
Thailand
UK
Ukraine
Senior Vice President, Innovative Medicines and Research & Development as of 1 January 2023
Ownership of shares 31 Dec 2023: 7,098 Orion Corporation B shares
Career in Orion
2023- Senior Vice President, Innovative Medicines and Research & Development
2020-2022 Senior Vice President, Research and Development
2019-2020 Vice President of Oncology Research
Earlier career
2018-2019 Senior Director Research, Respiratory Inflammation and Autoimmunity, Medimmune, AstraZeneca, The United States
2017-2018 Vice President, Head of Lung Immunity, AstraZeneca, Sweden
2014-2017 Vice President, Head of Translational Science, AstraZeneca, Sweden
2014 Director of the Department of Vaccinations and Immune Protection; Finnish Institute for Health and Welfare (THL)
2005-2014 Research Professor, Head of the Immune Response Unit, Department of Vaccines and Immune Protection; Finnish Institute for Health and Welfare (THL)
Current key positions of trust
Member of the Board of Directors: Tampere University Foundation 2021-
Former key positions of trust
2005-2014 Permanent expert at the European Medicines Agency (EMA)
More than 200 peer-reviewed scientific articles in internationally renowned scientific journals (as in Science Translational Medicine, Cell Host Microbes, JAMA, New England Journal of Medicine, the Lancet, and Journal of Immunology).
